Max Schloemann interviewed by AM Best TV about Telemedicine

By |2021-03-30T20:01:11+00:00February 8th, 2021|Malpractice Insurance, Telemedicine|

Max Schloemann, Founder and CEO of MEDPLI, was recently interviewed by AM Best TV about his thoughts on telemedicine, telemedicine’s future growth, and what its growth means for insurance providers and physicians. “[Telemedicine] has been gaining traction now for probably the last 5 years,” Max advises when asked if telemedicine is gaining in [...]

Max Schloemann’s 2021 Medical Malpractice Insurance Predictions Featured on Managed Healthcare Executive

By |2021-03-30T20:00:42+00:00January 29th, 2021|Malpractice Insurance, Telemedicine|

MEDPLI’s founder and independent medical malpractice insurance broker Max Schloemann was recently published on the Managed Healthcare Executive website. His article, titled “Medical Malpractice Insurance Planning for a Healthy Practice in 2021” breaks down what practitioners can expect of the liability insurance landscape in 2021. Max warns that providers should expect an increase [...]

4 New Telemedicine Tips from the Joint Commission’s Safety Advisory

By |2021-03-30T19:55:54+00:00October 21st, 2020|Malpractice Insurance, Telemedicine|

The Joint Commission just released its new safety advisory detailing actions for telemedicine best practices in the midst of a pandemic. Here are tips on how to protect yourself and your patients. To help physicians manage the exponential increase in providing telemedicine services to patients during the COVID-19 pandemic, The Joint Commission [...]

3 Big Takeaways from The Doctors Company Report on Telemedicine

By |2021-03-30T19:54:19+00:00August 17th, 2020|Malpractice Insurance, Telemedicine|

The Doctors Company recently released its report on the future of telemedicine. Here are MEDPLI’s 3 big takeaways from the report. The Doctors Company recently released its report on the future of telemedicine, Your Patient Is Logging on Now: The Risks and Benefits of Telehealth in the Future of Healthcare. The [...]

Go to Top